To prove that HSF1 inhibition may be helpful in overcoming monocyte-mediated drug resistance, we explored the effects of CL-43 in HCC cells incubated with THP1 and treated with CQ using the xCELLigence technique. This evidence concerns the gene HSF1 and hepatocellular carcinoma.